The Patient Navigation Research Program (PNRP) is a cooperative effort of nine research projects, with similar clinical criteria but with different study designs. To evaluate projects such as PNRP, it is desirable to perform a pooled analysis to increase power relative to the individual projects. There is no agreed-upon prospective methodology, however, for analyzing combined data arising from different study designs. Expert opinions were thus solicited from the members of the PNRP Design and Analysis Committee. Purpose To review possible methodologies for analyzing combined data arising from heterogeneous study designs. Methods The Design and Analysis Committee critically reviewed the pros and cons of five potential methods for analyzing combined PNRP project data. The conclusions were based on simple consensus. The five approaches reviewed included the following: (1) analyzing and reporting each project separately, (2) combining data from all projects and performing an individual-level analysis, (3) pooling data from projects having similar study designs, (4) analyzing pooled data using a prospective meta-analytic technique, and (5) analyzing pooled data utilizing a novel simulated group-randomized design. Results Methodologies varied in their ability to incorporate data from all PNRP projects, to appropriately account for differing study designs, and to accommodate differing project sample sizes. Limitations The conclusions reached were based on expert opinion and not derived from actual analyses performed.
Introduction
Patient navigation (PN) is a promising approach to reduce cancer disparities and refers to support and guidance offered to persons with abnormal cancer screening or a new cancer diagnosis in order to more effectively access the cancer care system [1] . The primary goals of navigation are to help patients overcome barriers to care and facilitate timely, quality care provided in a culturally sensitive manner. PN is intended to target those who are most at risk for delays in care, including individuals from racial and ethnic minority and lower income populations.
Although PN is an intervention that has clearly grown in popularity over the past decade, rigorous research on the efficacy of PN is still new [2] . A number of studies conducted on PN have been recently summarized [2, 3] . PN has generally shown improvements in timeliness of definitive diagnosis and initiation of cancer care.
The Patient Navigation Research Program (PNRP) is the first multicenter program to critically examine the role and benefits of PN. This program is sponsored and funded by the National Cancer Institute's (NCI) Center to Reduce Cancer Health Disparities (CRHCD), with additional support from the American Cancer Society. The 5-year program focuses on four common cancers (breast, cervical, colorectal, and prostate) with screening tests having evidence of disparate outcomes in underserved populations.
The PNRP is a cooperative effort of nine research projects (see Figure 1 ), the funding agencies, and an evaluation contractor. Each PNRP project focuses on one or more of the four specified cancers. All projects targeted populations at greater risk of disparate cancer outcomes, such as racial or ethnic minorities, the uninsured or underinsured, or persons of lower socioeconomic status (SES). As a cooperative endeavor, the PNRP utilizes a steering committee consisting of the nine project principal investigators, along with representatives from NCI-CRCHD, the American Cancer Society, and NOVA Research Company (NOVA), the evaluation contractor for the national outcome studies. In order to advise the steering committee on methodological issues, a design and analysis committee was created, which was composed of investigators having expertise in research design and methods from each project site, NOVA, and NCI-CRCHD.
The cooperative agreement did not require a uniform research design across all projects. This allowed for flexibility in implementing the PN intervention that would be sensitive both to the specific patient populations as well as local system-level factors at each project. In addition, the nature of PN requires involvement of the community with the development of the research strategy in collaboration with community partners. Thus, the research designs varied across projects and included traditional randomized clinical trials (RCT), group-randomized trials (GRTs), and nonrandomized quasi-experimental (QE) designs.
Despite the differences in research designs, there is significant clinical, measurement, and intervention homogeneity that would argue for a synthesis of the results in order to make a more generalizable statement about the PN intervention. All projects included characteristics specified by the steering committee, in order to support a single common evaluation of the PNRP. For example, all projects utilized the same inclusion and exclusion criteria, length of follow-up, and method of recording all data points. A common definition of PN intervention was employed. Navigators received common national training in this role and were assessed on the same competencies to attempt a uniform intervention across sites. All study designs share common well-defined outcomes with data elements from a single detailed data dictionary.
Navigation was hypothesized to shorten the time interval from cancer screening abnormality to definitive diagnosis, including increasing the proportion of patients who receive a definitive diagnosis. Navigation was also hypothesized to shorten the time interval from definitive diagnosis through initial cancer treatment for patients diagnosed with cancer as well as to improve satisfaction with diagnostic and treatment care. Each project assessed these time intervals by medical record abstraction, Clinical Trials 2012; 9: 176 -187 http://ctj.sagepub.com and the common data elements from all projects were uploaded to a national database to support a common evaluation of the PNRP. While each PNRP project was individually powered to address its primary hypotheses, a pooled analysis was desirable for many reasons. First, the increased statistical power from pooling data allows a more precise estimate of navigation effects across a variety of settings. In addition, while cancer screening abnormalities are common in primary medical care settings, cancer diagnoses are rare. The ability to address the hypothesis that navigation improves cancer care requires pooling data across projects for sufficient statistical power. Pooling of data also increases statistical power to explore navigation effects within patient subgroups at greater risk of adverse cancer outcomes (uninsured, racialethnic minorities, and persons of lower SES). Pooling increases the generalizability of the findings by demonstrating the effect across a variety of settings and populations. Finally, pooling data enables exploration of heterogeneity of navigation effects (e.g., contrasting models of navigation), something that is not possible within individual PNRP projects.
For these reasons, a pooled analysis to evaluate the overall PNRP was desirable. The design and structure of PNRP, however, created a challenge in developing a suitable analytic method to evaluate the overall program. The PNRP was clearly different from standard multicenter trials that utilize a singlestudy design with common shared protocols at all centers. In addition, while there was a common definition of navigation, its delivery could differ among the PNRP projects. The design variations across the distinct projects do not lend themselves to traditional methods for analyzing data from a multicenter research trial.
Others have recognized the need to analyze pooled data arising from heterogeneous study designs ('cross-design synthesis', 'multiparameter evidence synthesis') [4] . Methods for analyzing pooled data from published studies using meta-analytic techniques have been proposed [5, 6] . To our knowledge, however, there is no agreed-upon methodology for analyzing combined data arising from different study designs a priori or before each project has published their primary results, as opposed to retrospective analyses.
The Design and Analysis Committee was therefore charged with the task of reviewing potential methodologies for analyzing combined data from PNRP projects. This review took place over a series of conference calls, and the results of this assessment are presented below. In the following section, we describe each of the PNRP projects in detail and discuss five possible approaches that could be employed in this situation, including the pros and cons of each approach.
Methods

Summary of PNRP research designs
The PNRP is a collaborative effort involving nine separate research projects ( Table 1 ). Eight of the nine sites contributed data to the national data set. The ninth site focused solely on the American Indian/ Alaska Native population of the northwestern United States, and the data sharing agreements are specific to that setting. Each project designed the implementation of its intervention taking into account the factors that were unique to their health-care delivery system and patient population. Some projects were able to employ true experimental designs, while others implemented variations of QE designs. Four projects -Denver, Ohio, Rochester, and Tampa -implemented true experimental designs, using a random assignment of either individuals or clinics to the navigation or control conditions. Given adequate sample size, a random assignment allows the analysis to make the assumption that study conditions formed through this process are equivalent, and observed differences between control and navigation treatment conditions can be attributed to the navigation effect.
Denver and Rochester used a more classical RCT design and randomly assigned individuals to either a control condition or the intervention condition [7] . Standard methods are readily available for the analysis of data from a classic RCT. Ohio and Tampa used a GRT approach and randomly assigned groups (i.e., clinics) to either a control condition or a navigation condition. A GRT is a comparative study design in which identifiable groups (i.e., study units) are assigned at random to study conditions, and observations are made on members of those groups [8] ; they are also referred to as cluster-randomized trials [9] . Studies with different units of assignment and observation exist in many disciplines and pose a number of design and analytic problems not present when individuals are randomized to study conditions. A central problem is that the intervention effect must be assessed against the between-group variance rather than the withingroup variance [10] . Unfortunately, the betweengroup variance is usually inflated due to the positive intraclass correlation expected among responses from the members of the same identifiable group [11] . In addition, the degrees of freedom (dfs) available to estimate the between-group variance is normally less than that for the within-group variance when there are a limited number of groups per condition. The extra variation and limited df were identified by Cornfield [10] as the inherent penalties in group-randomized design. Ohio originally identified 12 participating clinics and stratified them according to clinic type -university-based clinic (n = 8) versus neighborhood health center (n = 4). Within clinic type, individual clinics were rank ordered on the proportion of African-American patients, and pairs were formed by clinics adjacent in rank. Clinics within each pair were then randomly assigned to either navigation or control conditions. This method of forming pairs should maintain balance between the two conditions on at least the variable that was used to rank the clinics in the first place. To the extent that this variable is also a surrogate for other variables (e.g., SES, insurance coverage) that might be correlated with the outcome, then this assignment process will permit a more direct interpretation of results. Data on these confounding variables can be examined for balance between the study conditions. Tampa identified 12 clinics nested within five distinct health-care organizations (the five organizations having 3, 3, 2, 2, and 2 clinics, respectively). There was a further constraint that for health-care organizations having 3 clinics, 1 was randomly assigned to be the control clinic and the remaining 2 clinics were designated as navigated clinics. Random assignment of clinics occurred within each health-care organization.
The Tampa and Ohio projects present cases where the number of units to be randomly assigned is small, and the degree to which equivalency between control and navigated conditions was achieved is of less certainty than the situation where several hundred individuals are randomly assigned. They also present cases where the usual analytic methods are inappropriate, and special methods must be used [8, 9] . This feature of these two projects substantially influenced the eventual choice of which approach would be used for the pooled analysis, as the potential approaches differed in their ability to employ a valid analysis for each project.
The remaining five projects -Boston, Chicago-Access, Chicago-VA, San Antonio, and Washington, DC -employed a QE design [12] , with the distinguishing feature that patients (or clinics) were not randomly assigned to conditions. The decision to use nonrandomized designs reflected the collaborations with community partners to develop and conduct the research. These projects are summarized below.
In the Boston project, six community health centers each developed a PN intervention at their clinic using a community-based participatory research process. Each health center either (1) actively navigated abnormal breast screening tests while serving as a control for cervical abnormalities or (2) actively navigated cervical cancer screening tests while serving as a control for breast abnormalities. The research team assigned health centers to navigation nonrandomly but in a fashion that ensured balance by race and ethnicity. Methods of identifying potential subjects were identical in the navigated and control conditions of the study.
The Chicago-Access project included 20 primary care sites: 19 clinics within a federally qualified health center (FQHC) network and 1 hospital-based ambulatory care center. The 19 FQHCs were assigned to the following conditions in a nonrandom fashion; 2 clinics strictly provided PN and no controls; 3 clinics provided PN, and after navigation ceased, they provided a small number of control patients for secondary patient self-reported outcomes; and 14 clinics provided only record-based control patients to assess primary outcomes. The hospitalbased ambulatory care center recruited similar numbers of navigated and control subjects using individual nonrandom assignment. Control clinics were selected because they had characteristics that were similar to the navigated sites on the basis of patient volume, racial/ethnic composition, and payer mix.
The Chicago-VA project was conducted within a single VA medical center. Patients with an abnormal prostate cancer screening test result were identified through the VA's electronic medical record system. Patients were selected to receive navigation if they presented to the urology clinic for an abnormal prostate cancer screening test follow-up on a clinic day designated for the navigation intervention. Patients who presented with an abnormal http://ctj.sagepub.com Clinical Trials 2012; 9: 176 -187 screen follow-up on a nonnavigation day were selected as controls. The Washington, DC project was conducted within eight unaffiliated clinical entities. Four (three large medical centers and one community clinic) enrolled both navigated and control patients. Three (a storefront mammography unit, a community clinic, and a preventive outpatient clinic within a large medical center) enrolled navigated patients only. One setting (a mobile mammography unit) enrolled control patients only. Women were enrolled into the navigated group when they attended one of the sites offering navigation. All controls were concurrent record-based subjects pro-portionally matched to the navigated patients in terms of age, race, and date of entry into the study. Controls were identified sequentially at all sites among woman who had not received PN and had reached diagnostic resolution.
The San Antonio project was conducted within 12 clinics (a public hospital ambulatory care clinic, a neighborhood health center, and FQHCs). Navigated breast patients were recruited from one specific clinic, and navigated cervical patients were likewise recruited from another specific clinic. Nonmatched, record-based controls were identified from clinics by provider/clinic staff referral and system queries for abnormal cancer screening tests. The same kinds of statistical analyses can be applied to data from quasi-experiments as from true experiments; it is the ability to directly interpret the findings and the confidence in the obtained results that separates these two kinds of designs. A random assignment eliminates many of the alternative plausible explanations for the obtained results that may be more difficult to eliminate in QE designs and facilitates generalizability of results to similar populations.
The Design and Analysis Committee considered the various study designs and proposed five possible analytic methods or approaches for a national evaluation of the major outcomes of the PNRP. Each approach was evaluated by the committee in regard to its strengths, weaknesses, and suitability to address the unique methodological issues of the PNRP. The results of that evaluation are presented below (see also Table 2 ).
Results
Approach 1: no presentation of the combined findings. Each project in the PNRP would be separately analyzed and reported as an independent study
One possible approach to evaluate the PNRP is to make no attempt to combine the data but instead present each project based on its own analysis. This approach would eliminate the difficulties in assessing the best method to combine data. This approach is useful if the findings of the individual projects are markedly different, allowing the readers to more easily see which projects had a significant effect and which did not. However, this approach does not provide a coherent summary of the overall PNRP program and leaves the synthesis of the findings to the reader. An understanding of the effects of PN from individual project analyses would only emerge over time as project results were published.
An example of such an analytic approach is the Centers for Medicare and Medicaid Services (CMS)funded program of 15 individual RCTs evaluating care coordination to improve quality of care, rehospitalization rates, and Medicare expenditures for Medicare beneficiaries. In this program, each project developed their own intervention and selected their own target diseases and study population, and established inclusion and exclusion criteria specific to their respective projects [13] . CMS developed a uniform evaluation procedure, using claims data and a standardized telephone survey. To summarize the effects of the overall program, the authors chose to present the data as 15 parallel RCTs, outlining the differences in each intervention and study population.
Interpretation of the findings primarily focused on the two projects that demonstrated positive effects, with an attempt to understand these findings in the context of differing study designs. This approach was reasonable in the setting where trials utilized markedly different designs and where the nature of the intervention varied significantly from project to project. In contrast, the PNRP program allowed different study designs but utilized a standard intervention strategy, study population, inclusion, and exclusion criteria. Also, basing a summary interpretation primarily on projects that were successful may yield a biased conclusion of the overall program effects. This bias would be lessened by an a priori analytic strategy not influenced by individual project results.
Approach 2: pool the data from all projects and analyze at the individual level ignoring any possible intraclass correlation
This analytical approach would combine data from all the projects, analyze at the individual level, and ignore any possible intraclass correlation. The primary analysis would be a test of the mean difference in time from abnormal finding to diagnostic resolution for the control condition compared to the navigated condition. The analysis could be performed using standard methods based on the general linear model [14] , such as t-tests or F-tests with df based on the number of individuals. While separate analyses could be performed for the different cancer sitesbreast, cervical, colorectal, prostate -the basic analytical approach would be the same.
The major advantages of this approach are that it would use all data from all projects in a single analysis and that it would rely on familiar methods based on the general linear model [14] . Pooled data also yield larger sample sizes and increased power and thereby permit the exploration of rarer events and the examination of the main effects on hypothesized subgroups, such as patients with comorbidities.
However, these advantages are offset by several serious disadvantages. A primary disadvantage is that this approach is inappropriate for GRTs and for quasi-experiments involving nonrandom assignment of identifiable groups [8, 9] . Stratification by project, including project either as a fixed or as a random effect, does not provide an adequate solution to this problem, as it would still ignore any positive intraclass correlation in any project that allocated groups rather than individuals. A potential disadvantage is that larger projects would contribute more information than smaller projects; if the results varied systematically by study size, the effects in the larger projects could wash out the effects in the smaller projects.
That may or may not be a problem, as one could make an argument in favor of weighting larger projects more heavily because they contribute more http://ctj.sagepub.com Clinical Trials 2012; 9: 176 -187
information and have effect estimates that are estimated with greater precision. If it was deemed a problem, the data could be analyzed weighting each project equally. We also note that this issue is not unique to Approach 2 but would apply equally to Approaches 2-5.
Approach 3: pooling data from projects with similar designs
Some of the projects employed similar research designs allowing the possibility of pooling raw data from projects that used similar research designs. For example, two projects employed a GRT design (Ohio and Tampa) that targeted shared cancer sites (breast, colorectal). This approach would analyze data from these two GRT projects, employ statistical methods that are appropriate to the study design, and stratify on project, so that overall results would be examined and differences between projects could also be evaluated. An advantage of this situation is that it would allow stratification by cancer site and project simultaneously. Individual-level data would be analyzed, but for these two projects, the intraclass correlation expected in the data would be addressed, and df would be based on the number of groups and not the number of individuals [8] [9] [10] . The analysis would be based on the general linear mixed model, addressing both the number of clusters or groups, the sample size within each cluster or group, and the intraclass correlation [15] . Two projects, Denver and Rochester, designed and conducted projects in which individuals within clinics were randomly assigned to either the control or navigated conditions. Data from these two projects could be pooled for a single analysis using Approach 2. The project Denver versus Rochester would be a stratification variable to test the interaction effect. The approach would use standard methods based on the general linear model [14] , such as t-tests or F-tests with df based on the number of individuals. An issue complicating this approach in this instance is that the major outcome variables are measuring different time frames; for Denver, the time is from abnormal finding to diagnostic resolution in 80% of its population and from cancer diagnosis to initiation of treatment in 20%, whereas for Rochester, the time for most of its patient population is from cancer diagnosis to initiation of treatment and/or completion of primary treatment. Hypothetically, however, it could be possible to pool the data across these two projects since both outcomes are measured in the same unit (number of days). This analytical approach could help answer the general question as to whether PN reduces the time to obtain standard quality cancer carewhether that 'care' is diagnostic resolution or initiation of cancer treatment. The challenge would be to find ways to appropriately combine and describe the relative merit of the data in reference to (1) the overall effects of PN on quality of cancer care and (2) specific differential effects of PN on cancer diagnostic resolution and initiation of cancer treatment.
While randomization ensures comparability of treatment arms on average, adjustment for patientlevel covariates is still advisable for several reasons [16] . First, despite randomization, imbalances in patient characteristics can occur by chance. Moreover, unadjusted analyses may yield results that are biased toward the null if there is heterogeneity of risk across strata [17] . Adjusted analyses may provide more precise estimates and a summary result closer to stratum specific results [17, 18] .
The primary advantage of Approach 3 is that it would base the analysis on the design of the project: RCTs would be analyzed as RCTs and GRTs would be analyzed as GRTs. Interpretation would be straightforward in both analyses. The primary disadvantages are that this approach would accommodate only four of the nine projects and present two sets of potentially conflicting results. With each analysis based on only two projects, power would also be reduced relative to other options, and questions may arise regarding unequal sample sizes of projects within the type of design.
Approach 4: prospective meta-analysis
Meta-analysis is the statistical synthesis of data from separate but similar projects that are combined, so that a quantitative summary of the pooled results can be obtained [19] [20] [21] [22] . An extension of this approach is prospective meta-analysis (PMA) in which studies are identified, evaluated, and determined to be eligible before the results of any of the studies become known [23] . PMA addresses some of the limitations of retrospective approaches to metaanalysis. For example, the retrospective analyses can be influenced by the individual study results, potentially affecting studies that are assessed (publication bias), study selection, what outcomes are assessed, and what treatment and patient subgroups are evaluated. In addition, PMA provides standardization across studies of instruments and variable definitions. PMA is an increasingly utilized approach reported in the literature [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] .
Using this PMA approach, data from each project would be analyzed separately using methods appropriate to the project design, and an effect size of the intervention (PN) would be calculated. These effect sizes would then be combined across projects using standard meta-analytic techniques to obtain a summary measure of the general effect of PN on the timely receipt of standard, quality cancer care [21] .
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A random-effects model would allow for different underlying intervention effects across the projects and is a widely used approach to deal with heterogeneity among the intervention effects estimated across the studies [21] . This approach has several advantages. It recognizes the idiosyncrasies across projects and treats the projects as random effects. It retains individual projects' research designs and allows for stratification according to research design quality. The PMA approach also avoids another important disadvantage of retrospective meta-analyses, where the researcher conducting the meta-analysis is dependent upon the data that are published in the literature or must request additional data from the authors. In the PNRP, all original data would be available for the analysis.
The data for each project would be analyzed separately, maintaining each project's research design and using statistical methods appropriate to the projects' designs with particular attention to the unit of assignment. Effect sizes could be examined by the type of design (individually randomized, group randomized, nonrandomized, or randomized vs. nonrandomized) to examine the differences in the estimated magnitude of the effect of PN as a function of research design type or quality of research design.
A potential disadvantage is the risk that the analyses performed for the PMA might differ from the analyses eventually reported by the individual projects. That risk can be minimized by requiring the individual projects to specify in advance their primary analysis plan. However, if projects plan their primary analysis with the inclusion of data they collected beyond the common data set, this analysis could not be completely replicated.
Approach 5: simulated group-randomized design
In this approach, pairs of matched groups would be created within each project to mimic a pair-matched GRT. The grouping would occur, so that the number of observations in each group formed within a particular project is balanced. The matching would be done such that the factors most highly associated with the outcomes were similarly distributed in both the control and navigated study conditions. Potential matching factors could include cancer site, health insurance coverage, ethnic and racial minority status, gender, and age. The distribution of these factors would first be examined to determine the overall balance between navigated and control patients within each individual cancer site. There is no requirement that the number of groups per project be equal or that group as defined for one end point be the same group defined for another end point.
For projects where group randomization of clinics was used, subjects from each individual clinic would remain together in a single group and not split into multiple groups even with a large sample size. In those cases where a 'group' was the unit of randomization or assignment, it would not be appropriate to split these units to obtain more groups; this would create groups that were not independent and violate the assumptions of the analysis plan. For some clinics that have small sample sizes, it may be necessary to combine across clinics and match on cancer site to attain a sufficient number of observations per group. For projects where individual randomization was used, groups would be created based on cancer site and date of index event, in order to create well-matched sets of navigated and control pairs. In the case where reasonable matching within strata has not been achieved with respect to the most influential covariates, it may be necessary to employ a mathematical model in the analysis to control for confounding.
Two methods of analysis could be considered for this approach, analysis of variance (ANOVA) and simple t-tests (or permutation tests for situations where the assumptions of normality are grossly violated). These methods have been described elsewhere [8, 34, 35] .
The strengths of this approach are that it would utilize all of the data from all eight projects, and it would help ensure balance in the number of observations in each constructed group within a project and in the number of groups in each condition. Balance is important in GRTs as it helps limit the potential impact of other problems that can occur in GRT data [36] . The size of groups should be similar enough in magnitude that weighting of effects would not be required. Another advantage of this method is that by creating comparable groupings across all PNRP projects, confounding that occurs at the level of groups can be controlled in the analysis. Potential disadvantages are that this is an untested and novel approach, and more importantly, it would not reflect the original design of most of the PNRP projects.
Discussion
The PNRP provides a real-life example of the analytic challenges in cross-design synthesis. The PNRP is clearly distinct from traditional multicenter randomized trials, and traditional methods of analysis of multicenter trials could not be applied [37] . Instead, we have considered five alternative approaches to the analysis of the PNRP data and examined their strengths and weaknesses. We anticipate that other research teams will face similar challenges in crossdesign synthesis of data from multisite studies as http://ctj.sagepub.com Clinical Trials 2012; 9: 176 -187 community-based participatory research gains strength as a methodology to address health disparities. The individual PNRP projects each had unique elements (designs, target populations, target conditions) creating variability between projects. Given this methodological heterogeneity, some might question whether a pooled analysis is even possible or appropriate. The Design and Analysis Committee believes that this situation reflects the reality of health disparities interventions. Interventions that address health disparities attempt to change processes or systems of care and, unlike pharmaceutical/ clinical interventions, will always be shaped by the unique characteristics of the communities in which they take place. The committee believes that a pooled analysis provides an effect estimate reflecting the spectrum of typical programs and provides better information to policy makers than trying to interpret specific favorable or unfavorable results. The committee also believes that there are inherent advantages in doing a program assessment systematically and prospectively with an a priori analysis plan.
Though we considered Approach 1, we judged the weaknesses to outweigh the strengths. The PNRP was created with the overarching goal of estimating the value of PN. The results from individual projects would certainly add to the research literature on this issue, but a unified summary would not emerge, and the readers would be left to find, evaluate, and synthesize the reports from the individual projects. In addition, this approach would not allow a thorough evaluation of heterogeneity of navigation effects across projects.
Another major disadvantage to Approach 1 was that a combined analysis should have greater power than a series of project-specific analyses. Pooling data allows sufficient sample size to explore effects of navigation across subpopulations of interest. Moreover, because the number of cancers arising in primary care settings is small, navigation programs that target primary care settings are unlikely to have sufficient numbers of cancers diagnosed to explore effects for each cancer site. By pooling data across cancer sites, there is a greater opportunity to examine the effects of navigation programs that target the full cancer continuum, from diagnosis through treatment.
Two analytic approaches that would pool data across projects were considered unacceptable by the Design and Analysis Committee. First, simply combining all data and conducting an individual-level analysis would ignore intraclass correlation and each project's unique study design, greatly increasing the likelihood of a type 1 error [8, 9] . In addition, projects having a large sample size would be weighted greater in Approach 2, which could unduly influence the findings [38] . Approach 3 would combine data only from projects having similar study designs but was deemed undesirable as it would exclude data from five of the nine projects.
Each of these remaining two approaches has potential strengths and weaknesses. The strengths of the PMA approach included an analytic method that is familiar to most readers, the ability to utilize data from all projects, the ability to account for unique research designs of each project, the ability to avoid problems common to many meta-analytic efforts by virtue of having complete access to original data, and its prospective approach. A meta-analysis conducted in advance of publication of individual project results could risk inconsistencies with later reports from the separate projects. Inconsistencies can be potentially managed through governance such as enforcing (or at least negotiating) agreed-upon analytic methods between that in the pooled analysis and that performed by individual PNRP projects. In addition, the differences in analytic methods and resultant discrepancies in reported results between pooled analysis and individual projects would need full disclosure and explanation in subsequent publications.
The advantages of Approach 5, which would construct a simulated pair-matched GRT, include utilizing data from all projects, ensuring balance between intervention and control conditions, and increased efficiency. Disadvantages include an untested analytic approach not familiar to the reviewers or readers; a less-transparent approach, which lacks adherence to the original designs of the PNRP projects; difficulty in achieving sufficient sample size per group; and finally, issues of weighting if some projects contribute more groups than others.
Adequate control of confounding is an important analytic issue in all the methods. In pooled analyses, confounding can occur at several levels: at the level of the PNRP project and cancer site, at the level of groups that occur within the pooled data (e.g., clinics or hospitals), and at the individual patient level. The factors that are highly correlated are difficult to separate in any analytic strategy. For example, three of the four sites examining cervical cancer are nonrandomized, whereas four out of five sites examining colon cancer are randomized. As a result, it will be difficult to isolate the potential effects of cancer site from potential effects of the study design. Confounding of group level (e.g., clinic) characteristics is also important in all analytic methods. While GRTs have inherent groups that can be assessed, a potential strength of Approach 5 is that it creates similar groupings within other study designs allowing for control of confounding at this level.
There were a number of limitations considered in our discussion of analytic approaches. First, the conclusions reached were based on expert opinion and Clinical Trials 2012; 9: 176 -187 http://ctj.sagepub.com not derived from actual analyses performed. Because data collection was still underway, there was no attempt to perform simulations, for example, that contrasted results from different analytic strategies or assumptions. Even so, programs that involve different designs and interventions addressing the same problem are not uncommon, and the examples of cross-design synthesis will likely increase. The PNRP faced an unusual situation in which timely program evaluation required the analysis of pooled data arising from projects having heterogeneous study designs. This situation could reemerge in future multisite, community-based participatory research projects. The PNRP Design and Analysis Committee considered several analytic approaches and concluded that a PMA was the most appropriate analytic strategy for PNRP and would be used as the primary method for the cross-design analysis of the PNRP.
